(Q24521308)

2 July 2017

0 references

1 reference

title

Neuroleptic malignant syndrome. (English)

1 reference

2 July 2017

Buckley PF

1

1 reference

PubMed ID

7897404

2 July 2017

Hutchinson M

series ordinal

2

1 reference

PubMed ID

7897404

2 July 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

2 July 2017

1 reference

2 July 2017

58

1 reference

2 July 2017

3

1 reference

2 July 2017

271-273

1 reference

Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome

2 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Metoclopramide-induced neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

The neuroleptic malignant syndrome, so-called. A survey of the world literature

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Spectrum concept of neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

The neuroleptic malignant syndrome: agent and host interaction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Risk factors for neuroleptic malignant syndrome. A case-control study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

A prospective analysis of 24 episodes of neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Significance of elevated levels of serum creatine phosphokinase in febrile diseases: a prospective study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

27 September 2017

The serotonin syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic malignant syndrome--follow-up study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Drug treatment of the neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic Malignant Syndrome in Parkinson's Disease After Withdrawal or Alteration of Dopaminergic Therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

A comparison of diagnostic criteria for neuroleptic malignant syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Neuroleptic malignant syndrome. May be caused by other drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

How "malignant" is the neuroleptic malignant syndrome?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

An atypical course of neuroleptic malignant syndrome.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Catatonia and the neuroleptic malignant syndrome--a single entity?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073359

Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link?

30 May 2018

1 reference

12 December 2020

A successful electroconvulsive treatment of neuroleptic malignant syndrome

1 reference

12 December 2020

Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families

1 reference

12 December 2020

Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients

1 reference

12 December 2020

Does clozapine cause neuroleptic malignant syndrome?

1 reference

12 December 2020

Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study

1 reference

12 December 2020

[A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses.]

1 reference

12 December 2020

Investigating young patients with dyspepsia

1 reference

12 December 2020

1 reference

12 December 2020

Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'

1 reference

12 December 2020

Incipient neuroleptic malignant syndrome?

1 reference

12 December 2020

Neuroleptic malignant syndrome: a study of CSF monoamine metabolism

1 reference

12 December 2020

Low serum iron and neuroleptic malignant syndrome

1 reference

12 December 2020

Declining frequency of neuroleptic malignant syndrome in a hospital population

1 reference

12 December 2020

Serum iron and neuroleptic malignant syndrome

1 reference

12 December 2020

Neuroleptic malignant syndrome

1 reference

12 December 2020

Concomitant treatment of neuroleptic malignant syndrome and psychosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.58.3.271

1 reference

2 July 2017

0 references

1 reference

PubMed ID

7897404